Ania M. Jastreboff
Yale University2 papersORCID 0000-0003-1446-0991OpenAlex
Papers
The New England Journal of MedicineHuman trial
Survodutide reduces weight in adults with diabetes and obesity
Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.
The New England Journal of MedicineHuman trial
Retatrutide reduces weight and pain in adults with obesity
Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.